These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2317347)

  • 1. Histological evaluation of prostatic cancer. (III): Reproducibility of assessment of tumour volume and its possible significance for prognosis.
    Svanholm H; Starklint H; Barlebo H; Olsen S
    APMIS; 1990 Mar; 98(3):237-43. PubMed ID: 2317347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological evaluation of prostatic cancer. (II): Reproducibility of a histological grading system.
    Svanholm H; Starklint H; Barlebo H; Olsen S
    APMIS; 1990 Mar; 98(3):229-36. PubMed ID: 2317346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological evaluation of prostatic cancer. 1. Reproducibility of tumour type.
    Svanholm H; Starklint H; Barlebo H; Olsen S
    APMIS; 1989 Aug; 97(8):699-704. PubMed ID: 2548542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter/intra-observer reproducibility of Gleason scoring in prostate adenocarcinoma in Iranian pathologists.
    Abdollahi A; Meysamie A; Sheikhbahaei S; Ahmadi A; Moradi-Tabriz H; Bakhshandeh M; Hosseinzadeh H
    Urol J; 2012; 9(2):486-90. PubMed ID: 22641492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra- and inter-observer agreement in histological assessment of canine soft tissue sarcoma.
    Yap FW; Rasotto R; Priestnall SL; Parsons KJ; Stewart J
    Vet Comp Oncol; 2017 Dec; 15(4):1553-1557. PubMed ID: 28133880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis of incidental (stage A) prostatic cancer].
    Uchida T; Go M; Egawa S; Ao T; Kuwao S; Yokoyama E; Mashimo S; Endo T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1293-300. PubMed ID: 7689124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental carcinoma of the prostate: histopathology and natural history.
    Nemoto R; Harada M; Uchida K; Koiso K; Abe R; Kato T
    Jpn J Clin Oncol; 1985 Dec; 15(4):619-23. PubMed ID: 2419598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer.
    Jørgensen T; Yogesan K; Skjørten F; Berner A; Tveter KJ; Danielsen HE
    Br J Cancer; 1995 May; 71(5):1055-60. PubMed ID: 7734299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra- and inter-observer reproducibility and generalizability of first trimester uterine artery pulsatility index by transabdominal and transvaginal ultrasound.
    Marchi L; Zwertbroek E; Snelder J; Kloosterman M; Bilardo CM
    Prenat Diagn; 2016 Dec; 36(13):1261-1269. PubMed ID: 27862084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.
    Allsbrook WC; Mangold KA; Johnson MH; Lane RB; Lane CG; Amin MB; Bostwick DG; Humphrey PA; Jones EC; Reuter VE; Sakr W; Sesterhenn IA; Troncoso P; Wheeler TM; Epstein JI
    Hum Pathol; 2001 Jan; 32(1):74-80. PubMed ID: 11172298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver reproducibility of modified Gleason score in radical prostatectomy specimens.
    Glaessgen A; Hamberg H; Pihl CG; Sundelin B; Nilsson B; Egevad L
    Virchows Arch; 2004 Jul; 445(1):17-21. PubMed ID: 15156317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage A prostate cancer from pathologist's viewpoint.
    Golimbu M; Glasser J; Schinella R; Morales P
    Urology; 1981 Aug; 18(2):134-6. PubMed ID: 7269013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
    O'Loughlin M; Andreu X; Bianchi S; Chemielik E; Cordoba A; Cserni G; Figueiredo P; Floris G; Foschini MP; Heikkilä P; Kulka J; Liepniece-Karele I; Regitnig P; Reiner A; Ryska A; Sapino A; Shalaby A; Stovgaard ES; Quinn C; Walsh EM; Zolota V; Glynn SA; Callagy G
    Breast Cancer Res Treat; 2018 Aug; 171(1):1-9. PubMed ID: 29774470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer.
    Wolters T; Roobol MJ; van Leeuwen PJ; van den Bergh RC; Hoedemaeker RF; van Leenders GJ; Schröder FH; van der Kwast TH
    Eur Urol; 2010 May; 57(5):821-9. PubMed ID: 19664875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reproducibility of malignancy grading in prostatic cancers using the Gleason-Böckling system].
    Kiss F; Lakner G; Csellár M; Nagy P; Tóth A; Vittay G
    Orv Hetil; 1997 May; 138(19):1195-9. PubMed ID: 9235527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.
    Epstein JI; Oesterling JE; Walsh PC
    J Urol; 1988 May; 139(5):980-4. PubMed ID: 3361676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The updated grading system of prostate carcinoma: an inter-observer agreement study among general pathologists in an academic practice.
    Al Nemer AM; Elsharkawy T; Elshawarby M; Al-Tamimi D; Kussaibi H; Ahmed A
    APMIS; 2017 Nov; 125(11):957-961. PubMed ID: 28913842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interobserver variability in Gleason histological grading of prostate cancer.
    Ozkan TA; Eruyar AT; Cebeci OO; Memik O; Ozcan L; Kuskonmaz I
    Scand J Urol; 2016 Dec; 50(6):420-424. PubMed ID: 27416104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.